Table 1.
Factors | Graphs | Groups | Median (Year) | Minimum (Day) | Maximum (Year) | Log Rank Test (Mantel-Cox) |
---|---|---|---|---|---|---|
All observations (n=94) | Fig. 3a | - | 3.39 | 87 with p = 0.99 | 11.61 with p = 0.00 | - |
Age | Fig. 3b | <55 | 2.40 | 156 with p = 0.93 | 11.45 with p = 0.00 | x2 = 3.88 (p = 0.049*) |
≥55 | 4.22 | 87 with p = 0.98 | 11.01 with p = 0.00 | |||
Stage (FIGO) | Fig. 3c | Stage 1 | 5.24 | 1021 with p = 88 | 11.01 with p = 0.00 | x2 = 25.38 (p = 0.000**) |
Stage 2 | 5.44 | 114 with p = 0.96 | 11.45 with p = 0.00 | |||
Stage 3 | 3.52 | 87 with p = 0.97 | 10.94 with p = 0.00 | |||
Stage 4 | 2.03 | 112 with p = 0.96 | 3.17 with p = 0.00 | |||
The ration of PD-L1 number of the positive square | Fig. 4a | <0.05 | 4.21 | 87 with p = 0.99 | 11.45 with p = 0.00 | x2 = 3.08 (p = 0.079) |
≥0.05 | 3.06 | 114 with p = 0.95 | 9.06 with p = 0.00 | |||
The number of TPS | Fig. 4b | =0 | 3.90 | 112 with p = 0.99 | 11.45 with p = 0.00 | x2 = 3.29 (p = 0.070) |
>0 | 3.17 | 87 with p = 0.96 | 9.06 with p = 0.00 | |||
PDL1 stromal TIL score | Fig. 4c | 0 | 4.21 | 112 with p = 0.98 | 11.45 with p = 0.00 | x2 = 8.62 (p = 0.035*) |
1 | 3.39 | 114 with p = 0.95 | 10.94 with p = 0.00 | |||
2 | 0.97 | 307 with p = 0.83 | 3.06 with p = 0.17 | |||
3 | 1.28 | 87 with p = 0.88 | 9.06 with p = 0.00 | |||
PD-L1 intratumoral TIL score | Fig. 4d | 0 | 4.21 | 112 with p = 0.98 | 11.45 with p = 0.00 | x2 =8.62 (p = 0.058) |
1 | 3.39 | 114 with p = 0.94 | 10.94 with p = 0.00 | |||
2 | 0.96 | 87 with p = 0.83 | 5.44 with p = 0.00 | |||
3 | 1.19 | 248 with p = 0.75 | 9.06 with p = 0.00 |
*p<0.05, **p<0.01.